Market News (Page 30) - TendieTensor

Market News Page 30 of 287 • 7,151 articles

Fiserv Stock Spikes As Judah Spinner's BlackBird Financial Reveals Large Stake

GlobeNewswire Inc. • Globe Newswire

Fiserv Stock Spikes As Judah Spinner's BlackBird Financial Reveals Large Stake

01/06/2026 10:00 AM • BlackBird Financial, a hedge fund founded by Judah Spinner, has announced a significant ownership stake in Fiserv, Inc., a global financial-technology and payments infrastructure company. Spinner expressed confidence in Fiserv's competitive moat, embedded position in financial systems, and new CEO Mike Lyons' turnaround strategy, despite near-term challenges. With adjusted net income exceeding $5 billion and a market cap around $33 billion, BlackBird views the investment as undervalued with strong long-term growth prospects.

ODV - Mentioned as the project option provider, with no significant direct impact from the current drilling results
FISV - BlackBird Financial established a significant ownership position based on confidence in Fiserv's embedded market position, strong switching costs, reliable cash generation ($5B+ adjusted net income), and new CEO Mike Lyons' strategic direction. The investment thesis emphasizes long-term value despite near-term difficulties, with expectations for earnings growth over the next 5-10 years.

#hedge fund investment #financial technology #payments infrastructure #competitive moat #value investing #CEO leadership #long-term outlook

Swift Navigation Breaks the Autonomy Cost Barrier, Integrating High-Integrity GNSS with NVIDIA DRIVE AGX Platform

GlobeNewswire Inc. • Na

Swift Navigation Breaks the Autonomy Cost Barrier, Integrating High-Integrity GNSS with NVIDIA DRIVE AGX Platform

01/06/2026 10:00 AM • Swift Navigation announced a collaboration with NVIDIA to integrate high-precision GNSS positioning with the NVIDIA DRIVE AGX platform through the new Starling SAL Plugin for DriveWorks. The integration aims to reduce autonomous vehicle localization costs and complexity by offloading absolute positioning to satellite-based systems rather than relying solely on expensive optical sensors, enabling centimeter-level accuracy positioning.

NVDA - NVIDIA benefits from this partnership by enhancing its DRIVE AGX platform's capabilities, making it more attractive to automotive OEMs by solving a critical localization challenge. The integration expands the ecosystem value of DriveWorks and positions NVIDIA as the standard platform for autonomous vehicle development.

#autonomous driving #GNSS positioning #localization #sensor fusion #cost reduction #high-precision positioning #ASIL certification #software-defined vehicles

First Merchants Corporation to Report Fourth Quarter 2025 Financial Results, Host Conference Call and Webcast

GlobeNewswire Inc. • Na

First Merchants Corporation to Report Fourth Quarter 2025 Financial Results, Host Conference Call and Webcast

01/06/2026 10:00 AM • First Merchants Corporation (NASDAQ: FRME) announced it will release fourth quarter 2025 financial results on January 26, 2026, followed by an earnings conference call and webcast on January 27, 2026 at 9:00 a.m. ET. The company also declared a cash dividend of $0.36 per common share payable on December 19, 2025.

FRME - The article is a routine earnings announcement and dividend declaration with no indication of positive or negative performance. It is a standard corporate disclosure providing information about upcoming financial results reporting and shareholder distributions.

#earnings announcement #fourth quarter 2025 #conference call #cash dividend #financial results

Durin Debuts MagicKey(™): The First Multi-Factor Authentication for Home Entry

Benzinga • Prnewswire

Durin Debuts MagicKey(™): The First Multi-Factor Authentication for Home Entry

01/06/2026 10:00 AM • Durin, Inc. announced MagicKey, a multi-factor authentication system for home entry combining ultra-wideband proximity detection, facial recognition, and voice biometrics. The solution partners with five technology providers—Mauna Kea Semiconductors, Xailient, Sensory Inc., Silicon Labs, and Infineon Technologies—and will be available for purchase in Q1 2026. Door Manager is compatible with Philips 3000 Series Wi-Fi Retrofit Lock and designed to support the upcoming Aliro standard.

EMR - Listed as a key market player with no specific notable actions mentioned
IFNNY - Infineon is selected as a key technology partner providing enterprise-grade Wi-Fi + Bluetooth connectivity for the Door Manager product. The partnership validates Infineon's IoT solutions and expands its presence in the smart home security market.

#multi-factor authentication #smart home access #ultra-wideband technology #facial recognition #voice biometrics #digital car keys #privacy-safe AI #smart locks #IoT connectivity

OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit with the Schall Law Firm

01/06/2026 10:00 AM • The Schall Law Firm is seeking lead plaintiffs for a class action lawsuit against Blue Owl Capital Inc. (OWL) for securities fraud. The lawsuit alleges the company made false and misleading statements regarding significant pressure on its asset base due to BDC redemptions and undisclosed liquidity issues that would likely result in halted or limited redemptions. Investors who purchased securities between February 6, 2025 and November 16, 2025 are encouraged to participate.

SBGSY - Listed as a key market player with no specific notable actions mentioned
OWL - The company is accused of making false and misleading statements to the market, concealing significant pressure on its asset base from BDC redemptions and undisclosed liquidity issues. These allegations of securities fraud and material misrepresentation resulted in investor losses.

#securities fraud #class action lawsuit #Blue Owl Capital #BDC redemptions #liquidity issues #misleading statements

5 Stocks Wall Street Repriced Higher Heading Into 2026

Investing.com • Thomas Hughes

5 Stocks Wall Street Repriced Higher Heading Into 2026

01/06/2026 09:50 AM • Wall Street analysts have upgraded five tech stocks crucial to AI and data center growth, with bullish sentiment strengthened in Q4 2025. Alphabet, Micron, CrowdStrike, Amazon, and Datadog all received multiple analyst revisions and price target increases, with consensus forecasts pointing to double-digit upside potential ranging from 20% to 50% in 2026.

GOOG - 48 bullish revisions from 51 analysts, 30% quarterly increase in consensus price target, favorable EU regulatory ruling, advancing Gemini AI model, consensus price target implies 20% upside potential to $385

#AI stocks #analyst upgrades #price targets #tech stocks #data center #2026 outlook #bullish sentiment

Why Robinhood Stock Lost 12% in December

The Motley Fool • Jennifer Saibil

Why Robinhood Stock Lost 12% in December

01/06/2026 09:37 AM • Robinhood Markets stock dropped 12% in December due to falling cryptocurrency prices, as the company is highly exposed to crypto markets. Despite the monthly decline, Robinhood had a strong 2025 with stock up 204%, driven by rapid expansion into new financial products, growing user base (27.9 million accounts), and strong profitability (Q3 net income up 271%). Cryptocurrency trading accounts for over a third of transaction revenue, making the company vulnerable to crypto volatility.

HOOD - Mixed signals: negative short-term (12% December decline due to crypto volatility) but positive fundamentals (strong 2025 performance +204%, rapid user growth, 271% net income increase in Q3, expanding product offerings). The stock decline appears to be a temporary reaction to cryptocurrency price movements rather than fundamental business deterioration.

#stock decline #cryptocurrency exposure #financial services expansion #user growth #profitability #crypto volatility #trading platform

GlobeNewswire Inc. • Doubleverify

DoubleVerify Launches DV Authentic Streaming TV™ at CES 2026, An Industry First Solution Combining Media Quality and Brand Suitability Measurement with Dynamic AI Optimization to Power Superior Campaign Performance

01/06/2026 09:00 AM • DoubleVerify announced DV Authentic Streaming TV, an AI-powered solution combining media quality measurement, brand suitability controls, and dynamic optimization for connected TV advertising. The platform addresses industry challenges including $1 billion in quarterly misplaced spend and lack of transparency, offering unified pre-bid discovery, post-bid measurement, and AI-powered activation across streaming environments.

DV - DoubleVerify is launching a major new product that addresses significant industry pain points (15% of CTV spend misplaced, $1B quarterly waste, 70% of marketers lacking transparency). The solution represents technological advancement with AI-powered capabilities, unified measurement, and positions the company as an industry leader in streaming TV accountability. The announcement demonstrates product innovation and market expansion.

#streaming TV advertising #connected TV (CTV) #brand suitability #media quality verification #AI optimization #programmatic advertising #ad transparency #campaign measurement

M-tron Industries, Inc. Announces Exercise Results of Dividend Warrants Distributed in April 2025

Benzinga • Prnewswire

M-tron Industries, Inc. Announces Exercise Results of Dividend Warrants Distributed in April 2025

01/06/2026 08:55 AM • M-tron Industries (NYSE:MPTI) announced successful completion of its warrant dividend program, with 100% of available shares issued. The company generated approximately $27.7 million in gross proceeds from the exercise of 582,233 shares of common stock. The warrants, distributed in April 2025 with a $47.50 exercise price, were fully exercised by the December 23, 2025 expiration date following an early acceleration trigger achieved in October 2025.

MPTI - The company successfully executed a warrant dividend program generating $27.7 million in capital, achieved 100% participation rate, and management expressed confidence in shareholder support and the company's strategic direction. The capital raise strengthens the balance sheet for growth investments and supports critical aerospace and defense programs.

#warrant exercise #dividend warrant #capital raise #aerospace and defense #shareholder returns #balance sheet strengthening

FDA Flags Liver Injury Risk In Sanofi's Rejected Multiple Sclerosis Drug

Benzinga • Vandana Singh

FDA Flags Liver Injury Risk In Sanofi's Rejected Multiple Sclerosis Drug

01/06/2026 08:54 AM • The FDA issued a complete response letter rejecting Sanofi's tolebrutinib drug application for non-relapsing secondary progressive multiple sclerosis due to serious safety concerns. The regulatory agency identified six cases meeting Hy's Law criteria for severe drug-induced liver injury (DILI) during clinical trials, including one death requiring liver transplant. The FDA determined that a favorable benefit-risk profile could not be established for any patient subpopulation, citing both efficacy and safety concerns.

CRAQR - The bank reported nonrecurring losses from CAL that impacted its quarterly net income, suggesting some financial challenges with this entity.
SNY - The FDA rejected Sanofi's drug application for tolebrutinib due to serious liver injury risks identified in clinical trials, including one patient death. This represents a significant setback for the company's multiple sclerosis treatment pipeline and eliminates a potential revenue opportunity for treating nrSPMS patients.

#FDA rejection #tolebrutinib #multiple sclerosis #drug-induced liver injury #DILI #clinical trials #complete response letter #hepatotoxicity

Accenture To Acquire UK AI Firm Faculty To Scale Enterprise AI

Benzinga • Akanksha Bakshi

Accenture To Acquire UK AI Firm Faculty To Scale Enterprise AI

01/06/2026 08:48 AM • Accenture announced the acquisition of Faculty, a UK-based AI firm, to strengthen its enterprise AI capabilities. The deal adds over 400 AI specialists and Faculty's decision intelligence platform to Accenture's portfolio. Faculty's CEO Marc Warner will become Accenture's CTO. The acquisition is subject to regulatory approval with undisclosed financial terms.

CRAQU - The bank reported nonrecurring losses from CAL that impacted its quarterly net income, suggesting some financial challenges with this entity.
ACN - Strategic acquisition to expand AI capabilities and talent, strengthening competitive position in high-demand enterprise AI market. Adds 400+ specialists and proven decision intelligence platform.

#acquisition #artificial intelligence #enterprise AI #decision intelligence #AI safety #M&A

China's Chip Consolidation Accelerates With SMIC, Hua Hong Buyouts

Benzinga • Bamboo Works

China's Chip Consolidation Accelerates With SMIC, Hua Hong Buyouts

01/06/2026 08:48 AM • China's leading chipmakers SMIC and Hua Hong announced buyouts of government minority stakes in key subsidiaries, signaling accelerated consolidation in the semiconductor industry. SMIC will acquire 49% of SMIC Beijing for $5.81 billion, while Hua Hong will acquire 38.4% of Shanghai Huali Microelectronics for 8.3 billion yuan. This reflects Beijing's strategy of government-backed expansion followed by consolidation, though the sector has faced notable failures like Wuhan Hongxin's bankruptcy.

TSM - TSM is mentioned as a global competitor benchmark for Chinese chipmakers' consolidation efforts. No direct impact on TSM is indicated, though increased Chinese consolidation may intensify competition.

#semiconductor consolidation #China chip industry #government investment #wafer fabs #M&A activity #foundry capacity #technology competition

CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc. • Not Specified

CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

01/06/2026 08:00 AM • CG Oncology announced that its Chairman & CEO Arthur Kuan and President & COO Ambaw Bellete will present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026. The company is a late-stage clinical biopharmaceutical firm developing bladder-sparing therapeutics for bladder cancer patients, with recent data showing promising efficacy rates for its lead candidate cretostimogene grenadenorepvec in non-muscle invasive bladder cancer.

AAPL - Thiel significantly increased holdings by purchasing 79,181 shares, showing confidence in the company's future
CGON - The company is presenting at a major healthcare conference and has announced promising clinical data showing high efficacy rates (95.7% at 3-months, 84.6% at 6-months, 80.4% at 9-months) for its lead therapeutic candidate in high-risk bladder cancer patients, indicating progress in late-stage development.

#bladder cancer #immunotherapy #clinical trial #J.P. Morgan Healthcare Conference #non-muscle invasive bladder cancer #cretostimogene grenadenorepvec

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

GlobeNewswire Inc. • Na

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

01/06/2026 08:00 AM • Mdxhealth announced a collaboration with the University of Oxford to initiate Genomic Prostate Score (GPS) testing in the landmark UK ProtecT trial, the world's largest randomized clinical trial for localized prostate cancer treatment. This study aims to establish GPS as the first genomic classifier supported by randomized clinical trial evidence in an Active Surveillance cohort, potentially impacting clinical practice guidelines and payer coverage.

TSLA - Thiel dramatically reduced his Tesla holdings from 272,613 to 65,000 shares, indicating reduced confidence
MDXH - The company is advancing its GPS test through validation in the world's largest randomized prostate cancer trial, which could establish clinical credibility, influence treatment guidelines, and expand payer coverage. This represents significant progress in precision diagnostics and market positioning.

#prostate cancer diagnostics #genomic testing #clinical trial #precision medicine #GPS test #ProtecT trial #active surveillance

NuCana Appoints Theresa Bruce as Chief Operating Officer

GlobeNewswire Inc. • Nucana Plc

NuCana Appoints Theresa Bruce as Chief Operating Officer

01/06/2026 08:00 AM • NuCana plc announced the appointment of Theresa Bruce as Chief Operating Officer effective January 1, 2026. Bruce brings over 25 years of experience in oncology R&D and clinical operations. The appointment comes as NuCana plans to advance its pipeline with anticipated data readouts in 2026 for NUC-7738 and further characterization of NUC-3373, with cash runway extending into 2029.

NCNA - The appointment of an experienced COO with 25+ years in oncology R&D signals organizational strengthening and confidence in advancing the pipeline. The company has extended cash runway into 2029 and multiple anticipated data readouts planned for 2026, indicating progress and financial stability.

#Chief Operating Officer appointment #Theresa Bruce #NUC-7738 #NUC-3373 #clinical development #cancer therapy #Phase 1/2 study #melanoma #ProTide technology

Roadzen Announces Major Strategic Acquisition of AI-Powered Vehicle Repair Platform VehicleCare at CES 2026; Transaction Consideration Values Standalone India Business at ~$277 Million

Benzinga • Globe Newswire

Roadzen Announces Major Strategic Acquisition of AI-Powered Vehicle Repair Platform VehicleCare at CES 2026; Transaction Consideration Values Standalone India Business at ~$277 Million

01/06/2026 08:00 AM • Roadzen Inc. (NASDAQ: RDZN) announced the acquisition of VehicleCare, an AI-powered vehicle repair platform, for approximately $277 million in stock. The deal values Roadzen's India business at a 50% premium to its current public market price with no dilution to the parent company. VehicleCare is expected to contribute $10 million in revenue post-closing and will enable Roadzen to offer end-to-end claims management from digital decisioning to physical repair execution.

RDZN - The acquisition expands Roadzen's capabilities into repair execution, creating a full-stack claims operating system. The deal values the India subsidiary at a significant 50% premium to current market price, demonstrates investor confidence, and adds $10 million in expected revenue with synergy potential. The structure avoids dilution at the parent company level, which is favorable for existing shareholders.

#acquisition #AI-powered platform #vehicle repair #claims management #India business #workshop aggregation #insurance technology

Hallador Energy Appoints Barbara Sugg, Former CEO of Southwest Power Pool, to Join Board of Directors

GlobeNewswire Inc. • Na

Hallador Energy Appoints Barbara Sugg, Former CEO of Southwest Power Pool, to Join Board of Directors

01/06/2026 08:00 AM • Hallador Energy Company has appointed Barbara Sugg, former President and CEO of Southwest Power Pool, to its Board of Directors effective January 1, 2026, replacing David Hardie who resigned after 35 years. Sugg brings over three decades of energy industry leadership experience, including expertise in grid operations, transmission initiatives, and renewable energy integration.

HNRG - The appointment of an experienced energy industry executive with deep expertise in grid operations, transmission projects, and renewable energy integration strengthens the company's leadership and strategic capabilities. This is presented as a positive development to support the company's long-term growth strategy and asset value maximization.

#board appointment #Barbara Sugg #Southwest Power Pool #energy industry #grid operations #transmission #renewable energy integration

Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc. • Na

Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

01/06/2026 08:00 AM • Cogent Biosciences announced that CEO Andrew Robbins will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026. The company is developing precision therapies for genetically defined diseases, with bezuclastinib as its most advanced program for systemic mastocytosis and gastrointestinal stromal tumors. Recent positive trial results showed a 57-80% objective response rate in advanced systemic mastocytosis patients.

COGT - The company is presenting at a major healthcare conference and has demonstrated positive clinical trial results with high objective response rates (57-80%) for its lead drug bezuclastinib in advanced systemic mastocytosis, indicating strong clinical progress and investor interest.

#bezuclastinib #systemic mastocytosis #precision therapies #KIT D816V mutation #GIST #clinical trial #J.P. Morgan Healthcare Conference

Roper Technologies schedules fourth quarter 2025 financial results conference call

GlobeNewswire Inc. • Na

Roper Technologies schedules fourth quarter 2025 financial results conference call

01/06/2026 08:00 AM • Roper Technologies announced that its fourth quarter 2025 financial results will be released on January 27, 2026, before market open, with a conference call scheduled for 8:00 AM ET the same day. The company is a Nasdaq 100, S&P 500, and Fortune 1000 constituent that operates market-leading vertical software and technology-enabled products businesses.

ROP - The article is a routine earnings announcement with standard procedural information about results release and conference call timing. No material business developments, guidance changes, or performance metrics are disclosed that would indicate positive or negative sentiment. The mention of AI leadership appointments in a separate announcement suggests growth initiatives, but the main article focuses only on administrative details.

#Q4 2025 earnings #financial results #conference call #vertical software #acquisitions #shareholder value

IMTE Announces Receipt of Additional Delisting Determination Letter from Nasdaq

Benzinga • Prnewswire

IMTE Announces Receipt of Additional Delisting Determination Letter from Nasdaq

01/06/2026 07:50 AM • Integrated Media Technology Limited (NASDAQ: IMTE) has received an additional delisting determination letter from Nasdaq for failing to file a Form 6-K interim report for its second quarter. This adds to previous non-compliance issues regarding the failure to timely file its Form 20-F for the year ended December 31, 2024. The company has until January 30, 2026 to demonstrate compliance, with plans to present its views to the Nasdaq Hearings Panel by January 9, 2026.

MSFT - Thiel increased holdings by purchasing 49,000 shares, indicating strategic investment interest
IMTE - The company faces serious regulatory challenges with multiple delisting determination letters from Nasdaq due to failure to file required financial reports (Form 6-K and Form 20-F). The company is at risk of suspension and delisting from the Nasdaq Capital Market, representing a significant threat to its continued public trading status and investor confidence.

#delisting #Nasdaq #Form 6-K #Form 20-F #filing requirements #compliance #interim report

Is Thailand Poised For Economic Acceleration In 2026?

Benzinga • Mighty Wisdom

Is Thailand Poised For Economic Acceleration In 2026?

01/06/2026 07:41 AM • Thailand's economy shows potential for acceleration in 2026 driven by tourism recovery, emerging tech and EV manufacturing sectors, and expanding financial services. Despite structural challenges and global headwinds, the country's diversified growth drivers and supportive policies position it for renewed momentum.

BKKLY - As one of Thailand's largest lenders, Bangkok Bank stands to benefit from rising credit demand across consumer, SME, and corporate segments, plus expanding digital initiatives and regional footprint provide resilience.

#Thailand economy #economic growth 2026 #tourism recovery #electric vehicles #fintech #Southeast Asia #manufacturing #digital economy

Smartkem Signs Proof of Concept Agreement with Global Consumer Electronics Giant for MicroLED Wearables

GlobeNewswire Inc. • Smartkem, Inc.

Smartkem Signs Proof of Concept Agreement with Global Consumer Electronics Giant for MicroLED Wearables

01/06/2026 07:00 AM • Smartkem announced a 12-month paid proof-of-concept agreement with a major consumer electronics company to develop next-generation smart wearables featuring conformable MicroLED displays using Smartkem's organic thin-film transistor (OTFT) technology. The collaboration aims to address key wearables challenges including miniaturization, power consumption, and durability, with potential manufacturing on existing Gen2.5 production lines.

SMTK - The company secured a paid proof-of-concept agreement with a major consumer electronics player, validating its OTFT technology for commercial applications. This represents progression from platform validation to product-level execution in a high-growth market (projected to reach $186 billion by 2030), demonstrating market demand and commercial viability of their technology.

#MicroLED display #organic thin-film transistor (OTFT) #smart wearables #proof-of-concept #semiconductor technology #flexible displays #wearable market growth

Sitryx to attend J.P. Morgan Healthcare Conference 2026 showcasing pipeline of novel small molecule candidates targeting major autoimmune indications

GlobeNewswire Inc. • Sitryx Therapeutics

Sitryx to attend J.P. Morgan Healthcare Conference 2026 showcasing pipeline of novel small molecule candidates targeting major autoimmune indications

01/06/2026 07:00 AM • Sitryx Therapeutics, a clinical-stage biopharmaceutical company, will participate in the 44th Annual J.P. Morgan Healthcare Conference in January 2026. The company is advancing its lead program SYX-5219, a first-in-class oral PKM2 modulator for atopic dermatitis, with Phase 1b trials planned for Q1 2026. Additionally, SYX-1042, an itaconate mimetic, completed Phase 1 studies and is positioned to move to Phase 2 patient efficacy studies in 2026.

LLY - Eli Lilly is mentioned as a specialist investor in Sitryx's funding syndicate, indicating strategic interest in the company's immunology programs. However, this is a passive investment relationship with no direct operational involvement disclosed.

#PKM2 modulator #atopic dermatitis #autoimmune disease #clinical trial #oral therapy #immunology #J.P. Morgan Healthcare Conference

BitMEX Launches Equity Perps for 24/7 Stock Trading

GlobeNewswire Inc. • Bitmex Press

BitMEX Launches Equity Perps for 24/7 Stock Trading

01/06/2026 07:00 AM • BitMEX announced the launch of Equity Perps, a new derivatives product enabling 24/7 trading on major U.S. stocks and equity indices using cryptocurrency as collateral. The product supports up to 20x leverage on assets like Bitcoin and Tether, with initial offerings on stocks including Amazon, Apple, Tesla, Nvidia, and indices like S&P 500 and Nasdaq.

WALpA - Stock price fell 10.88% after disclosing a fraud-related lawsuit against a borrower, indicating potential financial and legal challenges
AMZN - Amazon is mentioned only as one of the available trading instruments on the new Equity Perps platform. The announcement does not contain any company-specific news or developments affecting Amazon itself.

#Equity Perps #derivatives #perpetual swaps #cryptocurrency collateral #24/7 trading #leverage trading #U.S. equities

Plug to Participate in Goldman Sachs Energy, CleanTech & Utilities Conference

GlobeNewswire Inc. • Not Specified

Plug to Participate in Goldman Sachs Energy, CleanTech & Utilities Conference

01/06/2026 07:00 AM • Plug Power Inc. announced its participation in the Goldman Sachs Energy, CleanTech & Utilities conference in Miami, Florida. President and CRO Jose Luis Crespo and VP of Investor Relations Roberto Friedlander will hold one-on-one meetings with institutional investors to discuss the company's strategic priorities in the hydrogen economy.

PLUG - The company is actively engaging with institutional investors at a major financial conference, demonstrating confidence in its strategic direction and commitment to investor dialogue. This proactive investor relations activity typically signals management confidence in the company's trajectory and hydrogen market positioning.

#hydrogen economy #investor relations #conference participation #strategic priorities #institutional investors